US Senate Report: Growing Drug Shortages Pose National Security Risk

Image copyright: Anadolu Agency/Getty Images [via NBC]

The Spin

Pro-establishment narrative

Congress is finally taking the drug shortage seriously and seeking solutions for it. Moving forward, it will seek to onshore production to the US, diversify where medical supplies come from, and provide incentives for manufacturers to produce less-profitable drugs. Establishing an early-warning system for shortages, and investing in advanced manufacturing technologies will also help the US tackle this problem.

Establishment-critical narrative

Politicians have had multiple opportunities to cut ties with China and bring drug manufacturing back home, but they’re beholden to their corporate donors, who favor the status quo and offshoring harmful to the US economy. This crisis is another reason why domestic re-industrialization — including biotech supply chains — needs to be central to addressing an issue like this.


Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!